Fundación Instituto Valenciano de Oncológia

Valencia 46009

0 studies enrolling now · 1 studies all time

What they study most

Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer, Metastatic Cervical Cancer

Studies at this site

• HER-Seq: A Blood-based Screening Study to Identify Patients With HER2 Mutations for Enrollment Into Clinical Research Studies of Neratinib — Stopped early